Nanotechnology integration for sars-cov-2 diagnosis and treatment: An approach to preventing pandemic

Syed Mohammed Basheeruddin Asdaq, - and Abu Md Ashif Ikbal, - and Ram Kumar Sahu, - and Bedanta Bhattacharjee, - and Tirna Paul, - and Bhargab Deka, - and Santosh Fattepur, - and Retno Widyowati, - and Joshi Vijaya, - and Mohammed Al mohaini, - and Abdulkhaliq J Alsalman, - and Mohd Imran, - and Sreeharsha Nagaraja, - and Anroop B. Nair, - and Mahesh Attimarad, - and Katharigatta N. Venugopala, - (2021) Nanotechnology integration for sars-cov-2 diagnosis and treatment: An approach to preventing pandemic. Nanomaterials, 11 (7). pp. 1-27. ISSN 2079-4991

[img] Text (FULLTEXT)
Artikel C-26.pdf

Download (6MB)
[img] Text (Kualitas Karil)
Kualitas Karil C-26.pdf

Download (456kB)
[img] Text (Similarity)
C-26_artikel_similarity.pdf

Download (8MB)
Official URL: https://www.mdpi.com/2079-4991/11/7/1841

Abstract

The SARS-CoV-2 outbreak is the COVID-19 disease, which has caused massive health devastation, prompting the World Health Organization to declare a worldwide health emergency. The corona virus infected millions of people worldwide, and many died as a result of a lack of particular medications. The current emergency necessitates extensive therapy in order to stop the spread of the coronavirus. There are various vaccinations available, but no validated COVID-19 treatments. Since its outbreak, many therapeutics have been tested, including the use of repurposed medications, nucleoside inhibitors, protease inhibitors, broad spectrum antivirals, convalescence plasma therapies, immune-modulators, and monoclonal antibodies. However, these approaches have not yielded any outcomes and are mostly used to alleviate symptoms associated with potentially fatal adverse drug reactions. Nanoparticles, on the other hand, may prove to be an effective treatment for COVID-19. They can be designed to boost the efficacy of currently available antiviral medications or to trigger a rapid immune response against COVID-19. In the last decade, there has been significant progress in nanotechnology. This review focuses on the virus’s basic structure, pathogenesis, and current treatment options for COVID-19. This study addresses nanotechnology and its applications in diagnosis, prevention, treatment, and targeted vaccine delivery, laying the groundwork for a successful pandemic fight.

Item Type: Article
Uncontrolled Keywords: COVID-19; nanotechnology; vaccines; sanitizers; biosensors
Subjects: R Medicine
R Medicine > RS Pharmacy and materia medica
R Medicine > RS Pharmacy and materia medica > RS1-441 Pharmacy and materia medica
R Medicine > RS Pharmacy and materia medica > RS200-201 Pharmaceutical dosage forms
Divisions: 05. Fakultas Farmasi > Farmakognosi Fitokimia
Creators:
CreatorsNIM
Syed Mohammed Basheeruddin Asdaq, --
Abu Md Ashif Ikbal, --
Ram Kumar Sahu, --
Bedanta Bhattacharjee, --
Tirna Paul, --
Bhargab Deka, --
Santosh Fattepur, --
Retno Widyowati, -NIDN0005017701
Joshi Vijaya, --
Mohammed Al mohaini, --
Abdulkhaliq J Alsalman, --
Mohd Imran, --
Sreeharsha Nagaraja, --
Anroop B. Nair, --
Mahesh Attimarad, --
Katharigatta N. Venugopala, --
Depositing User: Mr M. Fuad Sofyan
Date Deposited: 29 Apr 2023 03:48
Last Modified: 29 Apr 2023 03:48
URI: http://repository.unair.ac.id/id/eprint/125498
Sosial Share:

Actions (login required)

View Item View Item